Locally Advanced Breast Cancer
Showing 1 - 25 of 46
Locally Advanced Breast Cancer Trial in Beijing (Modified radical mastectomy for breast cancer, neoadjuvant therapy, Systematic
Recruiting
- Locally Advanced Breast Cancer
- Modified radical mastectomy for breast cancer
- +2 more
-
Beijing, ChinaYing Xu
Oct 6, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Stage I Trial in Shanghai (FWD1802, palbocilib)
Recruiting
- Metastatic Breast Cancer
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 26, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Worldwide (Samuraciclib, Elacestrant DiHCl)
Recruiting
- Metastatic Breast Cancer
- +2 more
- Samuraciclib
- Elacestrant Dihydrochloride
-
Orange City, Florida
- +27 more
Jul 19, 2023
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Breast Cancer Trial in Ocala (Samuraciclib, Fulvestrant)
Recruiting
- Metastatic Breast Cancer
- +2 more
-
Ocala, FloridaOcala Oncology Center PL DBA Florida Cancer Affiliates
Jul 19, 2023
Early-stage Breast Cancer, Locally Advanced Breast Cancer Trial in Singapore (Exercise Programme, Control)
Recruiting
- Early-stage Breast Cancer
- Locally Advanced Breast Cancer
- Exercise Programme
- Control
-
Singapore, Singapore
- +2 more
Jul 19, 2023
Locally Advanced Breast Cancer, Hormone Receptor Positive,HER2-negative Breast Cancer Trial in Jinan (letrozole)
Recruiting
- Locally Advanced Breast Cancer
- Hormone Receptor Positive,HER2-negative Breast Cancer
-
Jinan, Shandong, ChinaBreast Cancer Center, Shandong Cancer Hospital and Institute
Apr 11, 2023
Locally Advanced Breast Cancer, Chemo Effect Trial in Beijing (inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP)
Recruiting
- Locally Advanced Breast Cancer
- Chemotherapy Effect
- inetetamab with pertuzumab and paclitaxel/carboplatin (TCbIP) regimen
-
Beijing, ChinaNational Cancer Center/National Clinical Research Center for Can
Feb 28, 2023
Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Spain (Trastuzumab deruxtecan)
Not yet recruiting
- Locally Advanced Breast Cancer
- Metastatic Breast Cancer
- Trastuzumab deruxtecan
-
Cádiz, Andalucía, Spain
- +18 more
Feb 24, 2023
Early Breast Cancer, Locally Advanced Breast Cancer, Inflammatory Breast Cancer Trial in Canada, Mexico, Spain (drug, procedure,
Recruiting
- Early Breast Cancer
- +2 more
- Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)
- +6 more
-
Buenos Aires, Argentina
- +29 more
Jan 31, 2023
Real-World Data of Clinicopathological Characteristics and
Recruiting
- Early Breast Cancer
- +2 more
-
Barcelona, Spain
- +9 more
Jan 18, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Recurrent Breast Cancer Trial in London (Palbociclib, Avelumab)
Recruiting
- Triple Negative Breast Cancer
- +5 more
-
Manchester, Greater Manchester, United Kingdom
- +6 more
Jan 5, 2023
Triple Negative Breast Cancer, Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Trial in Aurora (Nab-paclitaxel,
Withdrawn
- Triple Negative Breast Cancer
- +4 more
- Nab-paclitaxel
- +3 more
-
Aurora, ColoradoUniversity of Colorado Hospital
Dec 2, 2022
Breast Tumors, Breast Cancer, Breast Tumors Trial in United States (Standard Therapy, AMG 386 with or without Trastuzumab, AMG
Recruiting
- Breast Neoplasms
- +10 more
- Standard Therapy
- +32 more
-
Birmingham, Alabama
- +35 more
Nov 17, 2022
Breast Cancer, Locally Advanced Breast Cancer Trial in United States (Sentinel Lymph Node Biopsy (SLNB))
Recruiting
- Breast Cancer
- Locally Advanced Breast Cancer
- Sentinel Lymph Node Biopsy (SLNB)
-
Miami, Florida
- +7 more
Nov 7, 2022
Breast Tumor, Breast Cancer, Breast Tumors Trial in Shanghai (Dalpiciclib, Pyrotinib, SHR-A1811)
Not yet recruiting
- Breast Neoplasm
- +9 more
- Dalpiciclib
- +15 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center Shanghai, China, 200032
Oct 13, 2022
Locally Advanced Breast Cancer Trial in Shanghai (pyrotinib)
Recruiting
- Locally Advanced Breast Cancer
-
Shanghai, Shanghai, ChinaRenji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Aug 11, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer Trial in United States (U3-1402)
Recruiting
- Metastatic Breast Cancer
- Locally Advanced Breast Cancer
-
Birmingham, Alabama
- +9 more
Jul 18, 2022
Human Epidermal Growth Factor Receptor 2-Positive Unresectable
Active, not recruiting
- Metastatic Breast Cancer
- Locally Advanced Breast Cancer
-
Athens, Greece
- +1 more
Jun 20, 2022
Metastatic Breast Cancer, Locally Advanced Breast Cancer, Hormone Receptor Positive Tumor Trial in Durham (Abemaciclib,
Recruiting
- Metastatic Breast Cancer
- +2 more
- Abemaciclib
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Jun 7, 2022
Locally Advanced Breast Cancer, Metastatic Breast Cancer Trial in Batumi, Tbilisi (Tenalisib)
Active, not recruiting
- Locally Advanced Breast Cancer
- Metastatic Breast Cancer
-
Batumi, Georgia
- +2 more
May 2, 2022
Estrogen Receptor-Positive, HER2-Negative, Locally Advanced Breast Cancer Trial in Korea, Republic of, United States (ZB716,
Recruiting
- Estrogen Receptor-Positive
- +3 more
-
Seattle, Washington
- +7 more
Mar 20, 2022
Circulating Tumor Cells in Locally Advanced or Metastatic Stage
Active, not recruiting
- Locally Advanced Breast Cancer
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 16, 2022
Metastatic Breast Carcinoma, Locally Advanced Breast Cancer, Cancer of Pancreas Trial in Brussels (68GaNOTA-Anti-HER2 VHH1)
Recruiting
- Metastatic Breast Carcinoma
- +13 more
- 68GaNOTA-Anti-HER2 VHH1
-
Brussels, Brussel, BelgiumUz Brussel
Dec 17, 2021